Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study

Figure 2

Reported time interval between SP administration and delivery. At baby delivery, women donated blood to measure sulphadoxine in their blood by HPLC (UV) and were interviewed to self-report on whether and when they received pyrimethamine-sulphadoxine (SP) during the pregnancy. Agreement between the HPLC result and self report was calculated by kappa analysis. The Figure shows: A. Variability in interval (weeks) between reported date of SP intake and baby delivery (median: 12 weeks, IQR: 8–18.8 weeks, see whiskers), B. Frequency distribution of the reported interval (SP input to delivery) for the mothers whose blood was analyzed for SDX. Histogram of reported interval (SP intake to delivery) for HPLC negative (C) and HPLC positive (D) mothers.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us